Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

VYNE Therapeutics Inc. - Common Stock (NQ:VYNE)

0.9977 +0.0697 (+7.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about VYNE Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Top stock movements in today's session.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
VYNE Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Forecasting The Future: 4 Analyst Projections For VYNE Therapeutics
Via Benzinga
Analyst Scoreboard: 4 Ratings For VYNE Therapeutics
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
FDA Puts VYNE Therapeutics Early-Stage Psoriasis Study On Hold
VYNE pauses VYN202 psoriasis trial after FDA clinical hold tied to animal toxicity data; separate vitiligo trial remains on track for mid-2025 results. 
Via Benzinga
Exposures Product Safety
These stocks that are showing activity before the opening bell on Friday.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
Recap: VYNE Therapeutics Q4 Earnings
Via Benzinga
Recap: VYNE Therapeutics Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
VYNE Stock Earnings: VYNE Therapeutics Misses EPS, Beats Revenue for Q2 2024
VYNE stock results show that VYNE Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
VYNE Stock Earnings: VYNE Therapeutics Beats EPS, Misses Revenue for Q1 2024
VYNE stock results show that VYNE Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Top 4 Health Care Stocks That May Rocket Higher In Q1
The most oversold stocks in the health care presents an opportunity to buy into undervalued companies. 
Via Benzinga
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Shares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted weaker-than-expected results for its second quarter. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning! 
Via InvestorPlace
Dow Surges Over 500 Points; Western Digital Announces Plan To Split Into Two Companies
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 500 points on Monday. The Dow traded up 1.67% to 32,959.68 while the NASDAQ rose 1.25% to 12,800.95. The... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Positive Momentum For VYNE Therapeutics' Psoriasis, Rheumatoid Arthritis Candidate - Analyst Expresses Encouragement
Earlier today, VYNE Therapeutics Inc (NASDAQ: VYNE) released new preclinical data showing the positive effect of its VYN202 in preclinical models of  
Via Benzinga
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash. 
Via Benzinga
Crude Oil Falls Over 3%; Miromatrix Medical Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.14% to 32,788.73 while the NASDAQ rose 0.98% to 12,766.33. The... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Vyne Therapeutics Stock Is Climbing
Vyne Therapeutics Inc. (NASDAQ: VYNE) shares are trading higher Monday after the company announced a private placement of $88 million and positive data from its Phase 1b trial. 
Via Benzinga
Nasdaq Gains Over 1%; McDonald's Reports Upbeat Earnings
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Monday. Following the market opening Monday, the Dow traded up 0.85% to 32,695.89 while the NASDAQ rose... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.